retatrutide and mounjaro ESC 2024: improves lipid cardiovascular risk profile in Phase II trial Mounjaro vs retatrutide

First championed by Danish drugmaker Novo Nordisk, the Glucagon-like-peptide-1 receptor agonist (GLP-1 receptor agonist) is a newer class of drugs indicated to treat type-2 diabetes in uncontrolled traditional therapies like metformin

Sun exposure as a risk factor for nuclear cataract

The realistic picture: B12 shots do not directly burn fat, but they correct a deficiency that can quietly work against you

Gi bn tham kho: 780.000 VN/l/90 vin

IV Needles: Lifelines in Critical Care Intravenous needle size selection directly impacts treatment efficiency and patient comfort across diverse clinical scenarios

That was one of the drawbacks of this study